MetaCap

Cardio Diagnostics Insider Trades

NASDAQ: CDIOHealth CareBiotechnology: In Vitro & In Vivo Diagnostic SubstancesUSD

1.60-0.05 (-3.03%)

At close: Nov 20, 4:00 PM ET · Delayed 15 min

Last 12 months

Purchases
0 · $0
Sales
0 · $0
Shares bought / sold
0 / 0
Net activity
Net buying $0

Cardio Diagnostics insider activity

No Cardio Diagnostics insider transactions were reported in the last 12 months; the table shows the most recent historical filings. The most recent filing shows Dogan Timur (Chief Technology Officer) buying 68,965 shares at $0.29 on Sep 6, 2024. Insider sales are common for compensation, tax and diversification reasons, while open-market purchases are rarer; tracking both helps put CDIO's ownership changes in context.

Summary generated from market data by MetaCap's automated system. Methodology

CDIO insider transactions

Cardio Diagnostics insider transactions
DateInsiderTypeSharesValueFiling
Sep 6, 2024Dogan MeeshanthiniChief Technology OfficerBuy68,965$20.00KForm 4
Sep 6, 2024Philibert RobertChief Medical OfficerBuy7,460$2.12KForm 4
Sep 6, 2024Philibert RobertChief Medical OfficerBuy26,615$7.64KForm 4
Sep 6, 2024Dogan TimurChief Technology OfficerBuy68,965$20.00KForm 4
Sep 6, 2024Dogan MeeshanthiniChief Executive OfficerBuy68,965$20.00KForm 4
Sep 6, 2024Dogan MeeshanthiniChief Executive OfficerBuy68,965$20.00KForm 4
Sep 6, 2024Dogan TimurChief Technology OfficerBuy68,965$20.00KForm 4

Transaction codes follow SEC Form 4: P = open-market purchase, S = open-market sale, A = grant or award, M = option exercise, F = shares withheld for taxes. About Form 4

Related